phytic acid has been researched along with Parkinson Disease in 4 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phytic acid (PA) is a naturally occurring constituent which exhibits protective action in Parkinson's disease (PD)." | 1.42 | Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice. ( Gai, X; Hou, L; Liu, C; Liu, L; Lu, T; Lv, Y; Wang, Y; Xu, P; Zhang, J; Zhang, L; Zhang, Z, 2015) |
| "Thirty-three patients of idiopathic Parkinson's disease (PD) and 25 volunteers were admitted to the study for comparison." | 1.29 | Radionuclide esophageal transit test in the detection of esophageal dysmotility in Parkinson's disease. ( Chia, LG; Hsu, CY; Kao, CH; Liao, SQ; Lin, WY; Wang, SJ; Yeh, SH, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Zhang, Z | 1 |
| Hou, L | 1 |
| Zhang, L | 1 |
| Zhang, J | 1 |
| Wang, Y | 1 |
| Liu, C | 1 |
| Xu, P | 1 |
| Liu, L | 1 |
| Gai, X | 1 |
| Lu, T | 1 |
| Mythri, RB | 1 |
| Harish, G | 1 |
| Bharath, MM | 1 |
| Xu, Q | 1 |
| Kanthasamy, AG | 1 |
| Reddy, MB | 1 |
| Lin, WY | 1 |
| Kao, CH | 1 |
| Wang, SJ | 1 |
| Hsu, CY | 1 |
| Liao, SQ | 1 |
| Chia, LG | 1 |
| Yeh, SH | 1 |
1 review available for phytic acid and Parkinson Disease
| Article | Year |
|---|---|
Therapeutic potential of natural products in Parkinson's disease.
Topics: Animals; Biological Products; Botulinum Toxins; Humans; Levodopa; Neuroprotective Agents; Nicotine; | 2012 |
3 other studies available for phytic acid and Parkinson Disease
| Article | Year |
|---|---|
Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Calcium-Binding Pro | 2015 |
Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Caspase 3; Cell Differentiation; Cell Survival; Cel | 2008 |
Radionuclide esophageal transit test in the detection of esophageal dysmotility in Parkinson's disease.
Topics: Aged; Esophageal Motility Disorders; Esophagus; Female; Humans; Male; Middle Aged; Organotechnetium | 1994 |